These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 22270166

  • 1. Effect of statins and anticoagulants on prostate cancer aggressiveness.
    Alizadeh M, Sylvestre MP, Zilli T, Van Nguyen T, Guay JP, Bahary JP, Taussky D.
    Int J Radiat Oncol Biol Phys; 2012 Jul 15; 83(4):1149-53. PubMed ID: 22270166
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer.
    Moyad MA, Merrick GS, Butler WM, Wallner KE, Galbreath RW, Kurko B, Adamovich E.
    Urology; 2005 Dec 15; 66(6):1150-4. PubMed ID: 16360430
    [Abstract] [Full Text] [Related]

  • 4. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
    Efstathiou JA, Skowronski RY, Coen JJ, Grocela JA, Hirsch AE, Zietman AL.
    Int J Radiat Oncol Biol Phys; 2008 Aug 01; 71(5):1302-8. PubMed ID: 18262732
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N, Smolkin ME, Bissonette E, Theodorescu D.
    Cancer; 2005 Jun 15; 103(12):2499-506. PubMed ID: 15852361
    [Abstract] [Full Text] [Related]

  • 9. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy.
    Cheung R, Tucker SL, Lee AK, de Crevoisier R, Dong L, Kamat A, Pisters L, Kuban D.
    Int J Radiat Oncol Biol Phys; 2005 Mar 15; 61(4):993-1002. PubMed ID: 15752878
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy.
    Nanda A, Chen MH, Moran BJ, Braccioforte MH, Dosoretz D, Salenius S, Katin M, Ross R, D'Amico AV.
    Int J Radiat Oncol Biol Phys; 2010 May 01; 77(1):147-52. PubMed ID: 19744800
    [Abstract] [Full Text] [Related]

  • 12. Young men have equivalent biochemical outcomes compared with older men after treatment with brachytherapy for prostate cancer.
    Burri RJ, Ho AY, Forsythe K, Cesaretti JA, Stone NN, Stock RG.
    Int J Radiat Oncol Biol Phys; 2010 Aug 01; 77(5):1315-21. PubMed ID: 20044216
    [Abstract] [Full Text] [Related]

  • 13. Relationship of statins to clinical presentation and biochemical outcomes after radical prostatectomy in Korean patients.
    Ku JH, Jeong CW, Park YH, Cho MC, Kwak C, Kim HH.
    Prostate Cancer Prostatic Dis; 2011 Mar 01; 14(1):63-8. PubMed ID: 20938462
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. No effect of statins on biochemical outcomes after radiotherapy for localized prostate cancer.
    Soto DE, Daignault S, Sandler HM, Ray ME.
    Urology; 2009 Jan 01; 73(1):158-62. PubMed ID: 18722651
    [Abstract] [Full Text] [Related]

  • 16. Impact of common medications on serum total prostate-specific antigen levels and risk group assignment in patients with prostate cancer.
    Nieder C, Norum J, Geinitz H.
    Anticancer Res; 2011 May 01; 31(5):1735-9. PubMed ID: 21617232
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy.
    Kollmeier MA, Katz MS, Mak K, Yamada Y, Feder DJ, Zhang Z, Jia X, Shi W, Zelefsky MJ.
    Int J Radiat Oncol Biol Phys; 2011 Mar 01; 79(3):713-8. PubMed ID: 20452139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.